Shaily Engineering Plastics Stock Leads 3 Healthy High Growth Picks

Recent reports show broad Eurozone manufacturing and services activity in growth territory, which points to a healthier backdrop for companies that can turn stronger demand into higher earnings. That is where the Healthy high growth potential screener comes in. It filters for stocks that analysts expect to grow earnings and that appear financially sound. This article highlights three stocks from the screener worth a closer look.

The stocks covered below are only a small sample from this idea, with the full screen surfacing 132 more companies that analysts expect to grow earnings and that also meet the financial health criteria. To identify your own highest conviction ideas, head straight to the Healthy high growth potential screener

Shaily Engineering Plastics is a precision plastics manufacturer focused on complex drug delivery and pharmaceutical packaging, including inhalers, insulin pens, auto injectors and other CDMO work that links directly to the Healthy high growth potential screener’s earnings growth theme. The company reports all its revenue from customised components of plastic and other materials, which totaled about ₹10.2 billion, and also supplies consumer, automotive, lighting and personal care products, exporting to around 40 countries. Shaily Engineering Plastics currently carries a market cap of roughly ₹152.8 billion.

For growth focused investors, Shaily Engineering Plastics offers a mix of healthcare linked earnings potential and export scale that is hard to ignore. The company is deeply involved in contract manufacturing of specialty pens and inhalers for global pharma clients. Analysts note the company’s focus on higher value healthcare volumes and its potential impact on revenue and margins over time. At the same time, its business is sensitive to GLP 1 and other drug adoption, regulatory approvals and utilisation risk on new capacity. This matters in the context of a premium P/E and a more leveraged balance sheet. For investors seeking exposure to medical device CDMO activity, this is a story that may warrant close monitoring, with both upside potential and execution risk.

Shaily Engineering Plastics is increasing its focus on higher value drug delivery volumes, yet its premium P/E and leverage raise real questions. Get the DCF valuation analysis for Shaily Engineering Plastics to see how that growth story compares with the numbers investors often miss.

Build your own drug delivery and CDMO shortlist

Shaily Engineering Plastics and the two other stocks in this article all came from a single screener, but the real value comes when you set the filters yourself. Use our flexible Screener to blend growth, valuation and balance sheet quality, or start with any of our curated Investing Ideas if you prefer ready made shortlists.

Sky Gold and Diamonds is a B2B jewellery manufacturer that designs, cuts, polishes and assembles gold and silver pieces for wholesalers, showrooms and retailers across India, with products ranging from rings and bangles to customized jewellery featuring natural and lab grown diamonds and colour gemstones. The company generated about ₹71,764 million in revenue from gold jewellery manufacturing and carries a market cap of roughly ₹124.5b, which gives it meaningful scale in a sector aligned with the Healthy high growth potential theme through multi channel growth in retail, wholesale and export sales.

Sky Gold and Diamonds gives you exposure to lightweight gold and diamond jewellery supplied to large organised retailers, backed by strong recent earnings momentum and high returns on equity. The growth story is built around higher margin studded pieces, everyday wearable designs and export expansion, supported by new leadership and a growing Dubai hub. At the same time, heavy reliance on gold price assumptions, elevated debt and a sizeable capex program mean execution really matters. If you want to understand whether this premium growth profile and capital structure still leave room for attractive long term returns, this is a business worth a closer look.

Sky Gold and Diamonds is benefiting from strong jewellery demand and ROE, yet its leveraged balance sheet and capex plans keep the story finely balanced. Read the analysis report for Sky Gold and Diamonds for the twist most investors are missing

Cemindia Projects is a civil and marine engineering contractor that builds complex maritime concrete structures such as jetties, berths, dry docks and ship lifts. This is a direct fit with the Healthy high growth potential screener’s focus on heavy marine and coastal infrastructure. The company reports all its ₹102,051 million revenue from construction services, primarily within India, reflecting a concentrated but sizeable contracting business. Cemindia Projects currently has a market cap of about ₹219 billion.

Cemindia Projects gives you exposure to large scale marine, metro and tunnelling work where complexity can support stronger earnings growth, and analysts already expect earnings and margins to improve from here. The order book, recent revenue of over ₹27,000 million for Q1 FY2027 and high Return on Equity hint at a business that can turn technical capability into profit. Yet the elevated P/E, high use of bank limits, reliance on group orders and a recent GST demand order mean execution quality and cash discipline really matter. For investors who want growth in specialist infrastructure but are prepared to watch funding and governance signals closely, this is a story that rewards deeper research.

Cemindia Projects is tying complex marine work, a sizeable order book and a high Return on Equity into a story that many investors might still be underestimating. Read the 3 key rewards and 1 important warning sign and see what could change if one key assumption breaks.

Seeking Alternatives Before Momentum Flies

Fresh opportunities do not stay under the radar for long. By the time the crowd arrives, the best entry points can be gone. Check these curated ideas and consider them early.

• Capture income from companies with robust payouts and solid balance sheets by scanning a curated set of reliable payers through the 426 dividend fortresses before yields start dropping.
• Explore potential upside in carefully selected gold producers that may benefit if attention swings back to hard assets by checking the 32 elite gold producer stocks while they are still under the radar for now.
• Target companies building the hardware and infrastructure behind artificial intelligence momentum with a focused list of enablers using the 55 AI infrastructure stocks while the theme remains in focus.

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com